{
    "clinical_study": {
        "@rank": "116111", 
        "arm_group": [
            {
                "arm_group_label": "Low dose oxytocin infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "oxytocin will be administered as an intravenous infusion at a rate of 0.33 units/min starting after fetal delivery upon umbilical cord clamping and continuing for a total of 30 minutes"
            }, 
            {
                "arm_group_label": "High dose oxytocin infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "oxytocin will be administered as an intravenous infusion at a rate of 1.33 units/min starting after fetal delivery upon umbilical cord clamping and continuing for a total of 30 minutes"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the differences in blood clotting seen in healthy\n      patients given two different doses of oxytocin following cesarean delivery. The secondary\n      objectives are to evaluate changes in blood pressure, rates of nausea and vomiting, and\n      differences in blood loss with the two separate doses of oxytocin."
        }, 
        "brief_title": "The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery", 
        "condition": "Coagulation Changes With Oxytocin", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  English speaking\n\n          -  Age > or = 18 yrs\n\n          -  Non-laboring women\n\n          -  cesarean delivery under spinal anesthesia with pfannenstiel incision\n\n          -  ASA I-III\n\n        Exclusion Criteria:\n\n          -  Height <5'0\"\n\n          -  Allergy to phenylephrine\n\n          -  Severe cardiac disease in pregnancy with marked functional limitations\n\n          -  Women receiving NSAIDS, aspirin or other anticoagulants\n\n          -  Subject enrollment in another study involving a study medication within 30 days of\n             cesarean delivery\n\n          -  Other physical or psychiatric condition which may impair the ability to cooperate\n             with study data collection"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02063568", 
            "org_study_id": "Pro00051122"
        }, 
        "intervention": {
            "arm_group_label": [
                "Low dose oxytocin infusion", 
                "High dose oxytocin infusion"
            ], 
            "intervention_name": "Oxytocin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 12, 2014", 
        "location": {
            "contact": {
                "email": "ashraf.habib@dm.duke.edu", 
                "last_name": "Ashraf S Habib, MB, BCh", 
                "phone": "919-668-6266"
            }, 
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27705"
                }, 
                "name": "Duke University Hospital"
            }, 
            "investigator": {
                "last_name": "Ashraf S Habib, MB, BCh", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "coagulation as assessed by ROTEM", 
            "safety_issue": "No", 
            "time_frame": "30 minutes after oxytocin infusion started"
        }, 
        "reference": [
            {
                "PMID": "23075633", 
                "citation": "Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012 Dec;109(6):851-63. doi: 10.1093/bja/aes361. Epub 2012 Oct 16. Review."
            }, 
            {
                "PMID": "20238255", 
                "citation": "George RB, McKeen D, Chaplin AC, McLeod L. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. Can J Anaesth. 2010 Jun;57(6):578-82. doi: 10.1007/s12630-010-9297-1. Epub 2010 Mar 18."
            }, 
            {
                "PMID": "23676375", 
                "citation": "Balki M, Erik-Soussi M, Kingdom J, Carvalho JC. Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro. Anesthesiology. 2013 Sep;119(3):552-61. doi: 10.1097/ALN.0b013e318297d347."
            }, 
            {
                "PMID": "22227638", 
                "citation": "Tita AT, Szychowski JM, Rouse DJ, Bean CM, Chapman V, Nothern A, Figueroa D, Quinn R, Andrews WW, Hauth JC. Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2012 Feb;119(2 Pt 1):293-300. doi: 10.1097/AOG.0b013e318242da74."
            }, 
            {
                "PMID": "21642611", 
                "citation": "Butwick A, Harter S. An in vitro investigation of the coagulation effects of exogenous oxytocin using thromboelastography in healthy parturients. Anesth Analg. 2011 Aug;113(2):323-6. doi: 10.1213/ANE.0b013e3182222a82. Epub 2011 Jun 3."
            }, 
            {
                "PMID": "9128840", 
                "citation": "Neuenschwander S, Pliska V. Effects of neurohypophyseal hormone analogues on blood clotting factor VIII and fibrinolytic activity in sheep. Eur J Pharmacol. 1997 Apr 4;323(2-3):205-13."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02063568"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Duke University", 
            "investigator_full_name": "Ashraf Habib", 
            "investigator_title": "Associate Professor of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "cardiac output changes with oxytocin", 
                "safety_issue": "No", 
                "time_frame": "from start of surgery until 30 min after oxytocin infusion started"
            }, 
            {
                "measure": "incidence of nausea and vomiting with oxytocin", 
                "safety_issue": "No", 
                "time_frame": "from start of surgery until 30 minutes after oxytocin started"
            }, 
            {
                "measure": "estimated blood loss with different doses of oxytocin", 
                "safety_issue": "No", 
                "time_frame": "upon completion of surgery"
            }, 
            {
                "measure": "changes in blood pressure with oxytocin", 
                "safety_issue": "No", 
                "time_frame": "from start of surgery until 30 minutes after oxytocin started"
            }
        ], 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}